Younhee Cho serves as a Senior Principal Scientist at Bristol Myers Squibb, where she plays a pivotal role in advancing biopharmaceutical research and development. With a robust background in project management and functional leadership, Younhee excels in overseeing cross-functional teams that integrate Drug Metabolism and...
Younhee Cho serves as a Senior Principal Scientist at Bristol Myers Squibb, where she plays a pivotal role in advancing biopharmaceutical research and development. With a robust background in project management and functional leadership, Younhee excels in overseeing cross-functional teams that integrate Drug Metabolism and Pharmacokinetics (DMPK), formulation science, and bioanalysis. Her expertise spans a variety of innovative modalities, including bispecific antibodies, antibody-drug conjugates, and protein degraders, positioning her as a key contributor to the development of next-generation therapeutics.
In her current role, Younhee leads critical projects that bridge the gap between early-stage research and clinical application, ensuring that novel drug candidates are both effective and safe for patients. Her proficiency in pharmacokinetics and her adept use of tools such as WinNonlin enable her to analyze complex data sets, driving informed decision-making throughout the drug development process. Younhee's technical skills in cell biology, biophysical chemistry, and advanced analytical techniques, including circular dichroism and size exclusion chromatography, further enhance her ability to characterize and optimize therapeutic candidates.
Younhee's commitment to innovation is evident in her collaborative approach, fostering synergy among diverse teams to tackle the challenges of biopharma R&D. Her leadership not only accelerates project timelines but also cultivates an environment of scientific excellence, ultimately contributing to Bristol Myers Squibb's mission of delivering transformative medicines to patients. With her extensive skill set and strategic vision, Younhee Cho continues to be a driving force in the biopharmaceutical landscape, shaping the future of drug development.
